Concepedia

Betty Chang

BC

Statistics

Publications

62

Citations

20.7K

H-Index

45

Active since

1998

Affiliations

Pharmacyclics (United States)(Current)

The University of Texas MD Anderson Cancer Center

Stanford University

Cornell University

The Ohio State University

Betty Chang is an author at Pharmacyclics (United States) specializing in medicine, cell biology, and cell signaling.

ORCID

Top concepts

Publications per year

1998–2024

62

Publications

62

Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia

John C. Byrd, Richard R. Furman, Steven Coutré et al. · New England Journal of Medicine · 2013 · 2.2K citations · Full text

A Mitochondrial Protein Compendium Elucidates Complex I Disease Biology

David J. Pagliarini, Sarah E. Calvo, Betty Chang et al. · Cell · 2008 · 2K citations · Full text

, , +6

Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma

Michael Wang, Simon Rule, Peter Martin et al. · New England Journal of Medicine · 2013 · 1.7K citations · Full text

The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy

Lee Honigberg, Ashley M. Smith, Mint Sirisawad et al. · Proceedings of the National Academy of Sciences · 2010 · 1.5K citations · Full text

, , +16

Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor Ibrutinib

Jennifer A. Woyach, Richard R. Furman, Ta-Ming Liu et al. · New England Journal of Medicine · 2014 · 1.2K citations · Full text

Rows per page

1–5 of 62